18 March 2020 : Clinical Research
Controlled Release of Oxycodone as an Opioid Titration for Cancer Pain Relief: A Retrospective Study
Shen Zhao123ABCDEFG, Chunwei Xu4ABCDEFG*, Rongbo Lin123ABCDEFGDOI: 10.12659/MSM.920598
Med Sci Monit 2020; 26:e920598
Abstract
BACKGROUND: In 2014, a Chinese expert consensus was proposed regarding a titration protocol with controlled-release (CR) oxycodone as a background dose for relieving the moderate to severe cancer pain. This work aimed to summarize its efficacy and safety in our hospital.
MATERIAL AND METHODS: The Good Pain Management (GPM) protocol comprises a CR morphine or oxycodone given every 12-hours as a background dose and an immediate-release (IR) opioid as a rescue dose. Cancer patients with moderate to severe cancer pain were treated with this protocol, and the successful titration (numerical rating scale [NRS] ≤3 within 3 days) rate was analyzed. SPSS was used for statistical analysis. Differences of variables between opioid intolerant patients and opioid tolerant patients were analyzed using the Mann-Whitney U test. The chi square test was used for comparison of frequencies in different groups. A P-value <0.05 was set as the significance level.
RESULTS: Among 257 enrolled patients, there were 179 opioid intolerant patients and 78 opioid tolerant patients. The successful titration rates were 91.1%, 94.4%, and 83.3% in the total population, in the opioid intolerant patients, and in the opioid tolerant patients, respectively. The successful titration rates and NRS were superior in the opioid intolerant patients compared to the opioid tolerant patients. The most common opioid adverse effects were constipation, somnolence, nausea, mouth dry, and vomiting; and no significant differences in side effects were found between groups.
CONCLUSIONS: Our study supports that the GPM titration protocol is effective for patients with moderate-severe cancer pain, and it is more effective for opioid intolerant patients.
Keywords: Management Audit, Oncology Service, Hospital, Therapy, Computer-Assisted, Adolescent, Aged, 80 and over, Analgesics, Opioid, cancer pain, Constipation, Delayed-Action Preparations, Dose-Response Relationship, Drug, Drug Administration Schedule, Nausea, Oxycodone, pain management, Pain Measurement, sleepiness, Vomiting, Xerostomia, young adult
Editorial
01 July 2026 : Editorial
Editorial: The WHO Identifies Ebola Disease Due to Bundibugyo Virus as a Public Health Emergency of International Concern (PHEIC) as Vaccine Development AcceleratesDOI: 10.12659/MSM.954627
Med Sci Monit 2026; 32:e954627
In Press
Clinical Research
Effect of Dexmedetomidine Hydrochloride Nasal Spray on Anxiety and Sleep in Patients Undergoing Gynecologic...Med Sci Monit In Press; DOI: 10.12659/MSM.952465
Clinical Research
Prognostic Value of Mortality Scoring Systems in Patients With Severe Burns: Identifying Key Predictors of ...Med Sci Monit In Press; DOI: 10.12659/MSM.951713
Laboratory Research
Evaluation of the Trueness and Precision of Cast, Milled-Cast, Milled, and 3D-Printed Post-and-Core Techniq...Med Sci Monit In Press; DOI: 10.12659/MSM.953491
Clinical Research
Outcomes After Minimally Invasive Intramedullary Nail Fixation and Locking Plate Fixation Among Patients Wi...Med Sci Monit In Press; DOI: 10.12659/MSM.952670
Most Viewed Current Articles
17 Jan 2024 : Review article 14,176,214
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,757,839
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,466,153
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 708,809
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






